These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Influence of weight on aminoglycoside pharmacokinetics in normal weight and morbidly obese patients. Bauer LA, Edwards WA, Dellinger EP, Simonowitz DA. Eur J Clin Pharmacol; 1983; 24(5):643-7. PubMed ID: 6873144 [Abstract] [Full Text] [Related]
23. Aminoglycoside clearance is a good estimate of creatinine clearance in intensive care unit patients. Jones TE, Peter JV, Field J. Anaesth Intensive Care; 2009 Nov; 37(6):944-52. PubMed ID: 20014601 [Abstract] [Full Text] [Related]
24. [Serum level-adjusted dosage of once-daily aminoglycoside therapy in critical illness: results of a prospective study]. Reimann IR, Meier-Hellmann A, Pfeifer R, Traut T, Schilling A, Stein G, Reinhart K, Hoffmann A. Anasthesiol Intensivmed Notfallmed Schmerzther; 1999 May; 34(5):288-95. PubMed ID: 10372218 [Abstract] [Full Text] [Related]
25. Disposition of tobramycin in patients with cystic fibrosis: a prospective controlled study. Levy J, Smith AL, Koup JR, Williams-Warren J, Ramsey B. J Pediatr; 1984 Jul; 105(1):117-24. PubMed ID: 6376743 [Abstract] [Full Text] [Related]
29. Increased glomerular filtration rate in patients with major burns and its effect on the pharmacokinetics of tobramycin. Loirat P, Rohan J, Baillet A, Beaufils F, David R, Chapman A. N Engl J Med; 1978 Oct 26; 299(17):915-9. PubMed ID: 692596 [Abstract] [Full Text] [Related]
30. [Pharmacokinetics and clinical observations of sisomicin, a newly developed aminoglycoside derivative (author's transl)]. Lode H, Kemmerich B, Koeppe P, Langmaack H. Dtsch Med Wochenschr; 1975 Oct 17; 100(42):2144-50. PubMed ID: 1164890 [Abstract] [Full Text] [Related]
31. Experience with a once-daily dosing program of aminoglycosides in critically ill patients. Buijk SE, Mouton JW, Gyssens IC, Verbrugh HA, Bruining HA. Intensive Care Med; 2002 Jul 17; 28(7):936-42. PubMed ID: 12122533 [Abstract] [Full Text] [Related]
32. Aminoglycoside pharmacokinetics: dosage requirements and nephrotoxicity in trauma patients. Townsend PL, Fink MP, Stein KL, Murphy SG. Crit Care Med; 1989 Feb 17; 17(2):154-7. PubMed ID: 2914447 [Abstract] [Full Text] [Related]
34. [Is endogenous creatinine clearance a sound basis for estimation of elimination half life of gentamicin?]. Rameis H, Hitzenberger G, Jaschek I, Graninger W. Dtsch Med Wochenschr; 1980 Nov 21; 105(47):1650-4. PubMed ID: 7439047 [Abstract] [Full Text] [Related]
35. Serum aminoglycoside clearance is predicted as poorly by renal aminoglycoside clearance as by creatinine clearance in critically ill patients. Hickling KG, Begg EJ, Perry RE, Atkinson HC, Sharman JR. Crit Care Med; 1991 Aug 21; 19(8):1041-7. PubMed ID: 1860329 [Abstract] [Full Text] [Related]
36. Hemodialysis elimination rates and clearance of gentamicin and tobramycin. Matzke GR, Halstenson CE, Keane WF. Antimicrob Agents Chemother; 1984 Jan 21; 25(1):128-30. PubMed ID: 6703676 [Abstract] [Full Text] [Related]
39. Population pharmacokinetics of aminoglycosides in critically ill trauma patients on once-daily regimens. Barletta JF, Johnson SB, Nix DE, Nix LC, Erstad BL. J Trauma; 2000 Nov 21; 49(5):869-72. PubMed ID: 11086778 [Abstract] [Full Text] [Related]
40. Serum cystatin C for the prediction of glomerular filtration rate with regard to the dose adjustment of amikacin, gentamicin, tobramycin, and vancomycin. Hermida J, Tutor JC. Ther Drug Monit; 2006 Jun 21; 28(3):326-31. PubMed ID: 16778715 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]